S. Savage

Phase I Trial of Pazopanib in Patients with Advanced Cancer

Herbert I. Hurwitz, Afshin Dowlati, Shermini Saini et al. · Clinical Cancer Research · 2009 · 411 citations · Full text

Safety, tolerability and pharmacokinetics of oral administration of GW786034 in pts with solid tumors

Herbert I. Hurwitz, Afshin Dowlati, S. Savage et al. · Journal of Clinical Oncology · 2005 · 74 citations

Solid Tumors, Medicine, Pharmacology +7

Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors

Maja J.A. de Jonge, Paul Hamberg, Jaap Verweij et al. · Investigational New Drugs · 2012 · 35 citations

Medicine, Pharmacology, Pharmacokinetic Study +7

Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors

A. Benjamin Suttle, H. Hurwitz, Afshin Dowlati et al. · Journal of Clinical Oncology · 2004 · 23 citations

Solid Tumors, Pathology, Pharmacotherapy +21

A phase I, open-label study of the safety and pharmacokinetics (PK) of pazopanib (P) and lapatinib (L) administered concurrently

Maja J.A. deJonge, S. Savage, Jaap Verweij et al. · Journal of Clinical Oncology · 2006 · 22 citations

Pharmaceutical Science, Erbb2 Tyrosine Kinases, Pathology +18